American Portfolios Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-63
Closed -$3.15K – 3551
2021
Q3
$3.15K Hold
63
– – ﹤0.01% 3026
2021
Q2
$3.5K Hold
63
– – ﹤0.01% 2965
2021
Q1
$2.95K Hold
63
– – ﹤0.01% 2877
2020
Q4
$2.74K Hold
63
– – ﹤0.01% 2618
2020
Q3
$2.31K Buy
+63
New +$2.14K ﹤0.01% 2559

Other funds holding HCAT

American Portfolios Advisors's HCAT Position: Q4 2021 in Review

American Portfolios Advisors sold out of Health Catalyst (HCAT) in Q4 2021, closing a stake of 63 shares — an estimated $3.15K sold.

American Portfolios Advisors first reported a position in HCAT in Q3 2020 and held it in 5 quarters. The position peaked at $3.5K in Q2 2021. 187 funds tracked by Wall St. Rank hold HCAT as of Q4 2021.

  • American Portfolios Advisors reported no remaining Health Catalyst position as of Q4 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 63 Health Catalyst shares in Q4 2021, an estimated $3.15K.
  • American Portfolios Advisors first reported a position in Health Catalyst in Q3 2020 and held it in 5 quarters.
  • American Portfolios Advisors's Health Catalyst position peaked at $3.5K in Q2 2021.
  • 187 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2021.

Based on American Portfolios Advisors's 13F filing for Q4 2021, filed 21 Mar 2023.